Daniel Lochner insider trades

Open-market stock purchases and sales by Daniel Lochner, Chief Financial Officer at Tectonic Therapeutic, Inc, from SEC Form 4 filings since Nov 4, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -32%.

Recent trades

DateStockTradeValue
Sep 25, 2026TECX Tectonic Therapeutic, IncSold (not open market)$12.3K
Sep 3, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Jun 11, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Mar 4, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Mar 4, 2026TECX Tectonic Therapeutic, IncBought (not open market)—
Feb 10, 2026TECX Tectonic Therapeutic, IncBought$130K
Feb 4, 2026TECX Tectonic Therapeutic, IncSold (not open market)$48.2K

Companies traded

  • TECX Tectonic Therapeutic, Inc: 2 buys, last Sep 25, 2026
  • OYST Oyster Point Pharma, Inc: 1 buy, last Jan 3, 2023

Get free alerts when Daniel Lochner files a new trade →